NASDAQ: PROF
Profound Medical Corp Stock Ownership - Who owns Profound Medical?

Insider buying vs selling

Have Profound Medical Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Arun Swarup MenawatCEO2025-05-1612,027$4.73
$56.89kBuy
Arun Swarup MenawatCEO2025-05-1510,003$4.33
$43.26kBuy

1 of 1

PROF insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PROF insiders and whales buy or sell their stock.

PROF Shareholders

What type of owners hold Profound Medical Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fil Ltd6.24%1,885,000$13.65MInstitution
Gagnon Securities LLC5.74%1,733,040$12.55MInstitution
Letko Brosseau Associates Inc3.27%986,250$7.14MInstitution
Gagnon Advisors LLC2.97%896,671$6.49MInstitution
Royce Associates LP2.85%859,906$6.23MInstitution
Rosalind Advisors Inc2.29%692,185$5.01MInstitution
Timelo Investment Management Inc2.00%603,539$4.37MInstitution
Arun Swarup Menawat1.94%587,089$4.25MInsider
Mmcap International Inc Spc1.66%500,859$3.63MInstitution
Royal Bank Of Canada1.61%485,920$3.52MInstitution

1 of 3

PROF vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PROF36.64%1.94%Net Buying
CVRX39.53%60.47%Net BuyingNet Selling
NNOX19.34%0.01%Net Buying
MASS53.39%46.61%Net BuyingNet Selling
ELMD31.32%68.68%Net Selling

Profound Medical Stock Ownership FAQ

Who owns Profound Medical?

Profound Medical (NASDAQ: PROF) is owned by 36.64% institutional shareholders, 1.94% Profound Medical insiders, and 61.41% retail investors. Arun Swarup Menawat is the largest individual Profound Medical shareholder, owning 587,089.00 shares representing 1.94% of the company. Arun Swarup Menawat's Profound Medical shares are currently valued at $4.36M.

If you're new to stock investing, here's how to buy Profound Medical stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.